These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 24838519)

  • 21. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
    Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
    BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Definition, epidemiology and impact of non-neurogenic overactive bladder].
    Phé V; Gamé X
    Prog Urol; 2020 Nov; 30(14):866-872. PubMed ID: 33220814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
    Chung SD; Liao CH; Chen YC; Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
    DuBeau CE; Morrow JD; Kraus SR; Creanga D; Bavendam T
    Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urgency is an independent factor for sleep disturbance in men with obstructive sleep apnea.
    Tsujimura A; Takao T; Miyagawa Y; Yamamoto K; Fukuhara S; Nakayama J; Kiuchi H; Suganuma N; Nakamura T; Kumano-Go T; Sugita Y; Nonomura N; Okuyama A
    Urology; 2010 Oct; 76(4):967-70. PubMed ID: 20381845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women.
    Teleman PM; Lidfeldt J; Nerbrand C; Samsioe G; Mattiasson A;
    BJOG; 2004 Jun; 111(6):600-4. PubMed ID: 15198789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Terminology and Pathophysiology of Overactive Bladder (OAB)].
    Höfner K
    Aktuelle Urol; 2016 Dec; 47(6):468-474. PubMed ID: 27598780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder?
    Giarenis I; Mastoroudes H; Srikrishna S; Robinson D; Cardozo L
    BJU Int; 2013 Aug; 112(4):501-7. PubMed ID: 23452071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total urgency and frequency score as a measure of urgency and frequency in overactive bladder and storage lower urinary tract symptoms.
    Chapple CR; Drake MJ; Van Kerrebroeck P; Cardozo L; Drogendijk T; Klaver M; Van Charldorp K; Hakimi Z; Compion G
    BJU Int; 2014 May; 113(5):696-703. PubMed ID: 24712917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining urinary urgency: patient descriptions of "gotta go".
    Coyne KS; Harding G; Jumadilova Z; Weiss JP
    Neurourol Urodyn; 2012 Apr; 31(4):455-9. PubMed ID: 22275170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urgency is the core symptom of female overactive bladder syndrome, as demonstrated by a statistical analysis.
    Hung MJ; Ho ES; Shen PS; Sun MJ; Lin AT; Chen GD;
    J Urol; 2006 Aug; 176(2):636-40. PubMed ID: 16813910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nocturia in patients with overactive bladder.
    Espuña-Pons M; Blasco P; Pérez M; Rebollo P
    Arch Esp Urol; 2010 Jun; 63(5):363-72. PubMed ID: 20587841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The overactive bladder: Epidemiology and morbidity.
    Tyagi S; Thomas CA; Hayashi Y; Chancellor MB
    Urol Clin North Am; 2006 Nov; 33(4):433-8, vii. PubMed ID: 17011378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder.
    Latini JM; Giannantoni A
    Expert Opin Pharmacother; 2011 May; 12(7):1017-27. PubMed ID: 21473706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score.
    Homma Y; Yoshida M; Seki N; Yokoyama O; Kakizaki H; Gotoh M; Yamanishi T; Yamaguchi O; Takeda M; Nishizawa O
    Urology; 2006 Aug; 68(2):318-23. PubMed ID: 16904444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of extracorporeal magnetic energy stimulation on bothersome lower urinary tract symptoms and quality of life in female patients with stress urinary incontinence and overactive bladder.
    Lo TS; Tseng LH; Lin YH; Liang CC; Lu CY; Pue LB
    J Obstet Gynaecol Res; 2013 Nov; 39(11):1526-32. PubMed ID: 23855601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the overactive bladder symptom score and the overactive bladder symptom score derived from the bladder diaries.
    Hikita KS; Honda M; Hirano S; Kawamoto B; Panagiota T; Muraoka K; Sejima T; Takenaka A
    Neurourol Urodyn; 2016 Mar; 35(3):349-53. PubMed ID: 25597478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study to investigate the associations of urinary concentrations of NO, ATP and derivatives with overactive bladder symptom severity.
    Firouzmand S; Young JS
    Exp Physiol; 2020 Jun; 105(6):932-939. PubMed ID: 32170890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural history of non-neurogenic overactive bladder and urinary incontinence over 5 years in community-dwelling older men: The concord health and aging in men project.
    Noguchi N; Chan L; Cumming RG; Blyth FM; Handelsman DJ; Waite LM; Le Couteur DG; Naganathan V
    Neurourol Urodyn; 2017 Feb; 36(2):443-448. PubMed ID: 26756291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.